BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15133261)

  • 1. Farnesol, a morphogenetic autoregulatory substance in the dimorphic fungus Candida albicans, inhibits hyphae growth through suppression of a mitogen-activated protein kinase cascade.
    Sato T; Watanabe T; Mikami T; Matsumoto T
    Biol Pharm Bull; 2004 May; 27(5):751-2. PubMed ID: 15133261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quorum sensing controls hyphal initiation in Candida albicans through Ubr1-mediated protein degradation.
    Lu Y; Su C; Unoje O; Liu H
    Proc Natl Acad Sci U S A; 2014 Feb; 111(5):1975-80. PubMed ID: 24449897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucanase induces filamentation of the fungal pathogen Candida albicans.
    Xu H; Nobile CJ; Dongari-Bagtzoglou A
    PLoS One; 2013; 8(5):e63736. PubMed ID: 23737947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolic response of Candida albicans to farnesol under hyphae-inducing conditions.
    Han TL; Cannon RD; Villas-Bôas SG
    FEMS Yeast Res; 2012 Dec; 12(8):879-89. PubMed ID: 22846172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of propranolol on hyphae formation signal in Candida albicans.
    Ueno Y; Maruyama N; Kanno M; Watanabe T; Ogasawara A; Mikami T; Matsumoto T
    Biol Pharm Bull; 2009 Jan; 32(1):129-31. PubMed ID: 19122294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The possible molecular mechanisms of farnesol on the antifungal resistance of C. albicans biofilms: the regulation of CYR1 and PDE2.
    Chen S; Xia J; Li C; Zuo L; Wei X
    BMC Microbiol; 2018 Dec; 18(1):203. PubMed ID: 30509171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Farnesol and cyclic AMP signaling effects on the hypha-to-yeast transition in Candida albicans.
    Lindsay AK; Deveau A; Piispanen AE; Hogan DA
    Eukaryot Cell; 2012 Oct; 11(10):1219-25. PubMed ID: 22886999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retigeric acid B attenuates the virulence of Candida albicans via inhibiting adenylyl cyclase activity targeted by enhanced farnesol production.
    Chang W; Li Y; Zhang L; Cheng A; Lou H
    PLoS One; 2012; 7(7):e41624. PubMed ID: 22848547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Farnesol and dodecanol effects on the Candida albicans Ras1-cAMP signalling pathway and the regulation of morphogenesis.
    Davis-Hanna A; Piispanen AE; Stateva LI; Hogan DA
    Mol Microbiol; 2008 Jan; 67(1):47-62. PubMed ID: 18078440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Boric acid destabilizes the hyphal cytoskeleton and inhibits invasive growth of Candida albicans.
    Pointer BR; Boyer MP; Schmidt M
    Yeast; 2015 Apr; 32(4):389-98. PubMed ID: 25612315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of Ras1 membrane localization during Candida albicans hyphal growth and farnesol response.
    Piispanen AE; Bonnefoi O; Carden S; Deveau A; Bassilana M; Hogan DA
    Eukaryot Cell; 2011 Nov; 10(11):1473-84. PubMed ID: 21908593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release from quorum-sensing molecules triggers hyphal formation during Candida albicans resumption of growth.
    Enjalbert B; Whiteway M
    Eukaryot Cell; 2005 Jul; 4(7):1203-10. PubMed ID: 16002646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candida albicans PHO81 is required for the inhibition of hyphal development by farnesoic acid.
    Chung SC; Kim TI; Ahn CH; Shin J; Oh KB
    FEBS Lett; 2010 Nov; 584(22):4639-45. PubMed ID: 20965180
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Kim H; Hwang JY; Chung B; Cho E; Bae S; Shin J; Oh KB
    Mar Drugs; 2019 Feb; 17(2):. PubMed ID: 30813382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans.
    Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ
    Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Farnesol-mediated inhibition of Candida albicans yeast growth and rescue by a diacylglycerol analogue.
    Uppuluri P; Mekala S; Chaffin WL
    Yeast; 2007 Aug; 24(8):681-93. PubMed ID: 17583896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiofilm and antifungal activities of medium-chain fatty acids against Candida albicans via mimicking of the quorum-sensing molecule farnesol.
    Lee JH; Kim YG; Khadke SK; Lee J
    Microb Biotechnol; 2021 Jul; 14(4):1353-1366. PubMed ID: 33252828
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Liu RH; Shang ZC; Li TX; Yang MH; Kong LY
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of antifungal drugs on proliferation signals in Candida albicans.
    Matsuki M; Kanatsu H; Watanabe T; Ogasawara A; Mikami T; Matsumoto T
    Biol Pharm Bull; 2006 May; 29(5):919-22. PubMed ID: 16651719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity and toxicity of farnesol towards Candida albicans are dependent on growth conditions.
    Langford ML; Hasim S; Nickerson KW; Atkin AL
    Antimicrob Agents Chemother; 2010 Feb; 54(2):940-2. PubMed ID: 19933803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.